Macrophage colony-stimulating factor (M-CSF) is a critical cytokine in the development of monocytic lineage and may have immunoregulatory properties. Here we show that peritoneal antigen presenting cells (APCs) treated with M-CSF produced decreased levels of proinflammatory cytokines IFN-γ, TNF-α and IL-12. These APCs treated with M-CSF + autoantigen peptide significantly suppressed antigenspecific T cell proliferation, induced regulatory CD4 + and CD8 + T cells in vitro and in vivo, and significantly suppressed experimental autoimmune encephalomyelitis (EAE). Thus, in vitro treatment of APCs with M-CSF + autoantigen can be a novel therapeutic option for autoimmune diseases.
Introduction
Antigen presenting cells (APCs) play a pivotal role in the induction and expansion of antigen-specific T cell responses (Lee and Iwasaki, 2007; Saalmüller, 2006) . Professional APCs can either promote or suppress immune responses depending on their stage of maturation or level of activation (Lee and Iwasaki, 2007; Saalmüller, 2006) . In mice, APCs that produce large quantities of IL-12 and IFN-γ induce Th1 responses; APCs that produce low amounts of IL-12 but a high level of MCP-1 preferentially induce Th2 responses, whereas APCs that produce a low level of IL-12 but a high level of IL-10 induce regulatory T cell (Tr) responses (de Jong et al., 2005) . In addition, our laboratory found that APCs of IL-12Rβ1 −/− mice, which lack both IL-12 and IL-23 signaling, exhibit bias toward inducing Th2 response (Zhang et al., 2003) . Dendritic cells (DCs) and macrophages are the two most important types of professional APCs, with similar functions and profiles of secreted cytokines (Lee and Iwasaki, 2007; Saalmüller, 2006; Unanue, 1984) . However, it has been found that, upon similar stimulation, such as with LPS + IFN-γ, DCs produced a high level of IL-12 but low level of IL-10, while macrophages produced high level of IL-10 but low level of IL-12 (Smith et al., 1998) . This indicates that macrophages might have a natural propensity for producing regulatory cytokines, making them potentially a good candidate for generation of APCs with tolerogenic function.
Function of APCs can be modified by cytokine treatment (Kosiewicz et al., 1994; Steinbrink et al., 1997; Wilbanks et al., 1992) . For example, in anterior chamber-associated immune deviation (ACAID), intraocular injection of antigen induces systemic and antigen-specific tolerance. Streilein and colleagues have suggested that in this model macrophages, under the influence of TGF-β produced in the ocular environment, acquire tolerogenic phenotype (Wilbanks et al., 1992; Hara et al., 1993) . Adherent peritoneal exudate cells (PEC, primarily MΦ) cultured with antigen and TGF-β in vitro induced immunosuppression in vivo upon adoptive transfer (Wilbanks et al., 1992; Hara et al., 1992) . Given the direct APC-T cell interaction, APCs that can
